Antithrombotic Drugs Market | Global Industry Trends, Size, Share & Analysis 2018-2026

1
GLOBAL ANTITHROMBOTIC DRUGS MARKET
FORECAST 2018-2026
2
(No Transcript)
3

• Globally, there has been a surge in the knee and
  hip replacement surgeries. Also, the NOACS are
  gaining increased adoption.
• Propelled by these factors, the global
  Antithrombotic drugs market is anticipated to
  evolve further at a CAGR of 6.83 over the
  forecast period of 2018-2026.

4

• The antithrombotic drug market is segmented on
  the basis of anticoagulants, antiplatelet and
  thrombin inhibitors.
• Over the coming years, factors like rising
  prevalence of coagulation disorders and
  healthcare and related industries are expected to
  grow continuously, which is anticipated to
  provide tremendous scope for the market to
  expand.
• However, issues like patent expiration and lack
  of NOACS antidotes in the market are threatening
  the market progress.

5
(No Transcript)
6
The Global Antithrombotic drugs market is
anticipated to grow at a CAGR of 6.83 between
2018 and 2026.
7
Some of the leading market players dealing in
antithrombotic drugs market include Abbot
Laboratories, Armetheon Inc, Baxter
International, Bayer, Boehringer Ingelheim Gmbh,
Bristol-Myers Squibb Co, Csl Behring, Daiichi
Sankyo Co. Ltd, Eli Lilly and Company, F.
Hoffmann-La Roche Ltd, GlaxoSmithKline, Johnson
Johnson, Merck Co, Novartis, Pfizer, and Sanofi.
8
(No Transcript)
9
(No Transcript)
10
(No Transcript)